By targeting multiple metabolic pathways, tirzepatide helps patients feel fuller longer, reduce cravings, and better manage calorie intake as part of a medically supervised weight loss plan
By regulating your appetite and managing hunger, Daily GLP-1 lets you focus on the fun stuff
How it differs: Dual agonist - activates both GLP-1 and GIP receptors (glucose-dependent insulinotropic polypeptide) Expected results: 20-22% total body weight loss (clinical trials) Slightly better than semaglutide on average Real-world: 30-50 pounds for someone starting at 200 pounds Dosing protocol: Week 1-4: 2.5mg once weekly Week 5-8: 5mg once weekly Week 9-12: 7.5mg once weekly Week 13-16: 10mg once weekly Week 17-20: 12.5mg once weekly Week 21+: 15mg once weekly (maximum) Use our peptide dosing guide for comprehensive dosing instructions across all peptides
Safety profile: high Mechanism: incomplete Optimal SC dose: unvalidated If you choose to use it, do so consciously: Start at the minimum effective dose, track your outcomes, and adjust your protocol based on YOUR physiology
Gastroenterology 152, 14191433
Human data is older, sparse, and conflicting
